Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Cash from Investing Activities: 2023-2025

Historic Cash from Investing Activities for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to $5.3 million.

  • Immunocore Holdings' Cash from Investing Activities rose 734.30% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.0 million, marking a year-over-year increase of 94.61%. This contributed to the annual value of -$355.1 million for FY2024, which is 6446.16% down from last year.
  • Per Immunocore Holdings' latest filing, its Cash from Investing Activities stood at $5.3 million for Q3 2025, which was up 117.27% from -$30.4 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Cash from Investing Activities registered a high of $9.7 million during Q1 2025, and its lowest value of -$350.3 million during Q2 2024.
  • In the last 3 years, Immunocore Holdings' Cash from Investing Activities had a median value of -$828,000 in 2024 and averaged -$34.2 million.
  • Per our database at Business Quant, Immunocore Holdings' Cash from Investing Activities tumbled by 25,013.33% in 2024 and then soared by 2,356.28% in 2025.
  • Immunocore Holdings' Cash from Investing Activities (Quarterly) stood at -$817,000 in 2023, then plummeted by 333.29% to -$3.5 million in 2024, then skyrocketed by 734.30% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, -$30.4 million for Q2 2025, and $9.7 million during Q1 2025.